Vaidya Chandra Prakash Cancer Research Foundation
About Vaidya Chandra Prakash ji
A Pioneer in Rasa Shastra and Ayurveda, Late Vaidya Chandra Prakash was born into a humble farming family in Chhabariya village, Sardhana tehsil, Meerut district. At a young age, he left his parental home and came under the mentorship of a revered Sanyasi, Guru Maharaj ji, a master of Yoga and Rasa Shastra. This spiritual and scholarly influence laid the foundation of his lifelong dedication to Ayurveda.
After completing his Prabhakar degree from Prayag, he pursued the Bhishak degree—a three-year formal training in Ayurveda—from Sanatan Dharma College, Lahore (now in Pakistan). He began his clinical practice in Niloha village, Meerut, preparing and using his own Rasa Aushadhies under the guidance of Guru Maharaj ji.
In 1945, he married Smt. Shashi Mukhi, daughter of Late Lakshmi Narayan Agarwal of Gagari (Bihar). Soon after, he moved to Muzaffarpur, where he treated several renowned personalities including Late Jayaprakash Narayan and Dr. Rajendra Prasad, the first President of India.
Vaidya Chandra Prakash gained wide acclaim for treating chronic and refractory conditions using classical Rasa formulations. By the early 1960s, he achieved a clinical milestone by successfully treating three diagnosed cases of Acute Lymphocytic Leukemia (ALL) with a Rasa formulation named Vallipani, developed by his Guru. However, the formulation couldn’t be replicated due to the absence of standardized SOPs at the time.
In 1956, he relocated to Meerut city to stay close to his Guru. He continued practicing Ayurveda with a strong foundation in Rasa Shastra, earning recognition for his ability to treat drug-resistant typhoid and other complex illnesses.
In 1982, he developed a breakthrough formulation named Amar, based on the principles of Gandhak Jarana (Sulphur assimilation), using Mercury, Copper, and Sulphur. Amar showed remarkable efficacy in cancer care, offering hope and healing to several patients.
Another significant contribution was Navjeevan, a formulation containing Silver Bhasma and Delphinium denudatum, which brought complete remission in a 10-year-old child diagnosed with Acute Promyelocytic Leukemia (APML) at AIIMS, New Delhi. This case drew the attention of the CCRAS (Ministry of AYUSH), which constituted a fact-finding committee. The committee acknowledged the therapeutic merit in his claims and recommended further research. Unfortunately, governmental support did not follow.
The Foundation
Vaidya Chandra Prakash Cancer Research Foundation is the research and development unit of Padaav. It is involved in various research activities in collaboration with various scientific institutes apart from being the documentation and publication desk of Padaav.
VCP Cancer Research Foundation (VCPCRF) was set up in 1988 by Padmashri Vaidya Balendu Prakash in the memory of his father, Late Vaidya Chandra Prakash ji. The aim of the organisation is to carry in-depth research in Ayurveda with more emphasis on Ras Shastra. Its mission is to validate the efficacy of Ayurvedic protocols for treating malignancies, chronic inflammatory, immunological, and metabolic disorders. VCPCRF is committed to scientifically back the efficacy of Ayurvedic products and protocols and has been involved in conducting research works on various subjects.
Our Partners
UPES, Dehradun
An MoU was signed between UPES and VCPCRF to carry out scientific endeavours for the scientific development of Ayurveda in the form of collaborative research, joint projects and joint seminars and conferences.
Indian Institute of Sciences, Bengaluru
The characterization and standardization study on Amar (the formulation used in the treatment of Pancreatitis) and Mandoor Bhasma was carried in collaboration with the Department of Inorganic and Physical Chemistry, IISc.
All India Institute of Medical Sciences, Delhi
Clinical and pharmacological studies on the Ayurvedic treatment protocol on Migraine have been carried at Department of Neurology and Pharmacology respectively.
GB Pant University of Agriculture and Technology, Pantnagar
An MoU was signed between GBPUAT and VCPCRF in 2021 for carrying interdisciplinary studies to develop the Ayurvedic treatment for Pancreatitis.
GSVM Medical College, Kanpur
A randomized controlled trial was carried at department of Pediatrics to study the efficacy of Ayurvedic formulation, IMMBO, on patients of Allergic Rhinitis.
Vipragen Biosciences, Mysuru
Vipragen, an AAALAC international, CDSCO and DSIR recognised Clinical Research Organisation has been the collaborative institute to carry various experimental studies to study the effect of Amar and IMMBO on animal models.
Featured Research
GSVM Medical College, Kanpur
Phase III Prospective, Randomized, Double blind, Active-controlled, Comparative, Parallel Group and Multicentric Clinical Study to Evaluate the efficacy, safety and tolerability of FDC of IMMBO-Herbo-mineral formula oral suspension/tablet versus FDC of Levocetirizine 2.5 mg + Montelukast 4 mg oral suspension/tablet in patients of Allergic Rhinitis conducted under Dr Yashwant Rao, Department of Pediatrics, GSVM Medical College, Kanpur (June 2022 – November 2022)
Vipragen Biosciences, Mysuru
Experimental study on “Immunomodulatory, anti-inflammatory and antiallergic (mast cell stabilization) activities of a herbo-mineral formulation-IMMBO” (August 2022 – July 2023)
Institute of Chemical Technology, Mumbai
Study on “Comparative Hepatoprotective Properties of Different Commercial Brands of Punarnava Mandoor” carried under Dr Sadhana Sathaye, Department of Pharmacy, Institute of Chemical Technology, Mumbai (February 2020 – February 2023)
Ongoing Projects
Central Council for Research in Ayurvedic Sciences
Ongoing project on “Development of metal-based formulation for the treatment of Acute Promyelocytic Leukemia”, sponsored by Central Council for Research in Ayurvedic Sciences (Started in 2019).
School Of Health Sciences, UPES
Ongoing project on “A Comprehensive Investigation of AMAR Formulation and Intervention for Pancreatitis”, carried by School of Health Science and Technology, UPES, Dehradun (Started in January 2025).